Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)

Wuhan Hvsen Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	5,404	1,660	2,364	3,356	4,735	4,413
Market Cap Growth	227.18%	-29.79%	-29.56%	-29.11%	7.30%	-
Enterprise Value	5,233	2,088	2,596	3,264	4,405	3,608
Last Close Price	26.81	9.97	14.04	19.45	26.69	24.74
PE Ratio	22.48	-	140.89	63.68	35.64	29.39
Forward PE	30.12	20.96	30.44	-	-	-
PS Ratio	3.24	1.38	2.32	3.28	4.75	5.68
PB Ratio	2.55	1.13	1.57	2.18	2.93	3.20
P/TBV Ratio	2.71	1.24	1.68	2.34	3.14	3.44
P/OCF Ratio	24.80	38.13	25.44	34.72	30.41	91.26
EV/Sales Ratio	3.14	1.74	2.55	3.19	4.42	4.64
EV/EBITDA Ratio	15.37	15.88	20.45	26.41	26.89	19.88
EV/EBIT Ratio	22.49	113.82	395.16	53.50	32.56	22.21
Debt / Equity Ratio	0.15	0.61	0.56	0.51	0.42	0.06
Debt / EBITDA Ratio	0.92	6.76	6.63	6.40	4.16	0.44
Asset Turnover	0.57	0.40	0.34	0.36	0.44	0.65
Inventory Turnover	4.88	4.22	3.78	3.72	4.06	4.92
Quick Ratio	1.32	1.08	1.25	1.42	2.70	3.03
Current Ratio	1.71	1.42	1.62	1.68	3.18	3.48
Return on Equity (ROE)	12.22%	-1.33%	1.10%	3.34%	8.86%	17.09%
Return on Assets (ROA)	4.95%	0.38%	0.14%	1.33%	3.76%	8.45%
Return on Invested Capital (ROIC)	10.62%	1.03%	0.40%	4.13%	12.73%	26.89%
Return on Capital Employed (ROCE)	10.50%	0.90%	0.30%	2.80%	6.00%	11.50%
Earnings Yield	3.99%	-1.21%	0.71%	1.57%	2.81%	3.40%
FCF Yield	2.25%	-9.09%	-3.87%	-9.90%	-9.39%	-4.14%
Dividend Yield	0.75%	1.07%	1.92%	1.54%	1.24%	1.10%
Payout Ratio	26.33%	-	349.40%	118.55%	36.08%	3.99%
Buyback Yield / Dilution	-8.54%	0.06%	-0.33%	0.19%	-12.59%	-18.45%
Total Shareholder Return	-7.80%	1.12%	1.59%	1.74%	-11.35%	-17.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.